Organisms | Evidence |
---|---|
Mus musculus (house mouse) | |
Rattus norvegicus (Norway rat) | |
Homo sapiens (human) | |
Drosophila melanogaster (fruit fly) | |
Streptococcus pneumoniae |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT2 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT1 | UDP-Gal |
|
R |
|
R | |
B3GALT5 | UDP-Gal |
|
R |
|
R |
Gene Symbol | Donor | Acceptor | Reducing terminal(Acceptor) | Product | Reducing terminal(Product) | Reference |
---|---|---|---|---|---|---|
B4GALT5 | (not applicable) |
|
[beta]-S-pNP |
|
[beta]-S-pNP | |
B4GALT3 | UDP-Gal |
|
Benzyl-[beta] |
|
Benzyl-[beta] | |
B4GALT4 | UDP-Gal |
|
[beta]-1-Benzl |
|
[beta]-1-Benzl | |
B3GALT2 | UDP-Gal |
|
Lemieux |
|
Lemieux | |
B4GALT4 | UDP-Gal |
|
[beta]-1-4-methyl-umbelliferyl |
|
[beta]-1-4-methyl-umbelliferyl |
Pathway Name | Organism |
---|---|
E.coli O152 | Escherichia coli |
E.coli O156 | Escherichia coli |
E.coli O158ac | Escherichia coli |
E.coli O159 | Escherichia coli |
E.coli O160 | Escherichia coli |
E.coli O161 | Escherichia coli |
E.coli O167 | Escherichia coli |
E.coli O168 | Escherichia coli |
E.coli O16H48K12 | Escherichia coli |
E.coli O170 | Escherichia coli |
RES 1b:b-dglc-HEX-1:5 2s:n-acetyl LIN 1:1d(2+1)2n
PubMed ID | Title | First Author | Publication Date | Source |
---|---|---|---|---|
35922441 | Identification of IOMA-class neutralizing antibodies targeting the CD4-binding site on the HIV-1 envelope glycoprotein | van Schooten J | 2022 Aug 03 |
|
35917590 | 1,6-epi-Cyclophellitol Cyclosulfamidate Is a Bona Fide Lysosomal α-Glucosidase Stabilizer for the Treatment of Pompe Disease | Kok K | 2022 Aug 02 |
|
35978678 | Discovery of Novel 2-Carbamoyl Morpholine Derivatives as Highly Potent and Orally Active Direct Renin Inhibitors | Iijima D | 2022 Aug 01 |
|
35649323 | Protecting-group- and microwave-free synthesis of β-glycosyl esters and aryl β-glycosides of N-acetyl-d-glucosamine | Hamaya Y | 2022 Aug 01 |
|
35915115 | Molecular and in vivo studies of a glutamate-class prolyl-endopeptidase for coeliac disease therapy | del Amo-Maestro L | 2022 Aug 01 |
|
35738398 | Structural insights into the function-modulating effects of nanobody binding to the integrin receptor αMβ2 | Jensen RK | 2022 Aug |
|
35474639 | And-1 O-GlcNAcylation regulates homologous recombination repair and radioresistance in colorectal cancer | Zhou Y | 2022 Apr |
|
34974534 | O-GlcNAcylation of MORC2 at threonine 556 by OGT couples TGF-beta signaling to breast cancer progression | Liu Y | 2022 Apr |
|
35033559 | Structural Basis for Blocked Excited State Proton Transfer in a Fluorescent, Photoacidic Non-Canonical Amino Acid-Containing Antibody Fragment | Henderson JN | 2022 Apr 30 |
|
35478188 | Broadly neutralizing antibodies against Omicron-included SARS-CoV-2 variants induced by vaccination | Chi X | 2022 Apr 27 |
|
Title | Authors | Source | Publication Date | PubMed ID |
---|---|---|---|---|
Dynamic glycosylation of the transcription factor CREB: a potential role in gene regulation. |
|
J Am Chem Soc | 2003 Jun 4 | 12769553 |
Effect of okadaic acid on O-linked N-acetylglucosamine levels in a neuroblastoma cell line. |
|
Biochim Biophys Acta | 1999 Oct 18 | 10572927 |
Regulation of a cytosolic and nuclear O-GlcNAc transferase. Role of the tetratricopeptide repeats. |
|
J Biol Chem | 1999 Nov 5 | 10542233 |
An N-terminal region of Sp1 targets its proteasome-dependent degradation in vitro. |
|
J Biol Chem | 1999 May 21 | 10329728 |
Vertebrate lens alpha-crystallins are modified by O-linked N-acetylglucosamine. |
|
J Biol Chem | 1992 Jan 5 | 1730617 |
GlyCosmos is a member of the GlySpace Alliance together with GlyGen and Glycomics@ExPASy.
Supported by JST NBDC Grant Number JPMJND2204
Partly supported by NIH Common Fund Grant #1U01GM125267-01
This work is licensed under Creative Commons Attribution 4.0 International
GlyCosmos Portal v4.2.1
Last updated: April 7, 2025